|
HY-101952-5mg
|
MedChemexpress LLC
|
Prostaglandin E2 [CAS 363-24-6]
|
|
COVID-19-immunoregulation
|
|
|
HY-101952-50mg
|
MedChemexpress LLC
|
Prostaglandin E2 [CAS 363-24-6]
|
|
COVID-19-immunoregulation
|
|
|
HY-101952-1mL
|
MedChemexpress LLC
|
Prostaglandin E2 [CAS 363-24-6] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
|
HY-P0002A-10mg
|
MedChemexpress LLC
|
Protirelin (acetate) [CAS 120876-23-5]
|
|
COVID-19-immunoregulation
|
|
|
HY-P0002A-100mg
|
MedChemexpress LLC
|
Protirelin (acetate) [CAS 120876-23-5]
|
|
COVID-19-immunoregulation
|
|
|
HY-P0002A-5mg
|
MedChemexpress LLC
|
Protirelin (acetate) [CAS 120876-23-5]
|
|
COVID-19-immunoregulation
|
|
|
HY-P0002A-50mg
|
MedChemexpress LLC
|
Protirelin (acetate) [CAS 120876-23-5]
|
|
COVID-19-immunoregulation
|
|
|
HY-P0002A-1mL
|
MedChemexpress LLC
|
Protirelin (acetate) [CAS 120876-23-5] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
|
HY-N6626-100mg
|
MedChemexpress LLC
|
Pyraclostrobin [CAS 175013-18-0]
|
|
COVID-19-immunoregulation
|
|
|
HY-N6626-250mg
|
MedChemexpress LLC
|
Pyraclostrobin [CAS 175013-18-0]
|
|
COVID-19-immunoregulation
|
|
|
HY-N6626-500mg
|
MedChemexpress LLC
|
Pyraclostrobin [CAS 175013-18-0]
|
|
COVID-19-immunoregulation
|
|
|
HY-N6626-1mL
|
MedChemexpress LLC
|
Pyraclostrobin [CAS 175013-18-0] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
|
HY-B2033-50mg
|
MedChemexpress LLC
|
Pyrimethanil [CAS 53112-28-0]
|
|
COVID-19-immunoregulation
|
|
|
HY-B2033-1mL
|
MedChemexpress LLC
|
Pyrimethanil [CAS 53112-28-0] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
|
HY-P99980-1mg
|
MedChemexpress LLC
|
Rabbit IgG1 Kappa , Isotype Control
|
|
COVID-19-immunoregulation
|
|
|
HY-P99980-5mg
|
MedChemexpress LLC
|
Rabbit IgG1 Kappa , Isotype Control
|
|
COVID-19-immunoregulation
|
|
|
HY-17598-1g
|
MedChemexpress LLC
|
Rafoxanide [CAS 22662-39-1]
|
|
COVID-19-immunoregulation
|
|
|
HY-17598-500mg
|
MedChemexpress LLC
|
Rafoxanide [CAS 22662-39-1]
|
|
COVID-19-immunoregulation
|
|
|
HY-17598-1mL
|
MedChemexpress LLC
|
Rafoxanide [CAS 22662-39-1] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
|
HY-P99979-1mg
|
MedChemexpress LLC
|
Rat IgG1 Kappa , Isotype Control
|
|
COVID-19-immunoregulation
|
|
|
HY-P99979-10mg
|
MedChemexpress LLC
|
Rat IgG1 Kappa , Isotype Control
|
|
COVID-19-immunoregulation
|
|
|
HY-P99979-5mg
|
MedChemexpress LLC
|
Rat IgG1 Kappa , Isotype Control
|
|
COVID-19-immunoregulation
|
|
|
HY-P99248-1mg
|
MedChemexpress LLC
|
Risankizumab [CAS 1612838-76-2]
|
|
COVID-19-immunoregulation
|
|
|
HY-P99248-10mg
|
MedChemexpress LLC
|
Risankizumab [CAS 1612838-76-2]
|
|
COVID-19-immunoregulation
|
|
|
HY-P99248-5mg
|
MedChemexpress LLC
|
Risankizumab [CAS 1612838-76-2]
|
|
COVID-19-immunoregulation
|
|
